A. Ernest Toth, Jr.

A. Ernest Toth, Jr.

Chief Financial OfficeratAquestive Therapeutics· In proxies 2023–2025

Pay in FY2025Aquestive Therapeutics stock +81.5% the same year

A. Ernest Toth, Jr. was paid $1.3M in FY2025 (Dec). Aquestive Therapeutics stock rose 81.5% that year.

Pay$100 in the stock at the end of FY22 → $406
Pay is from the Summary Compensation Table of each Aquestive Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aquestive TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +389%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?